Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2017TheranosticsOpen Access

Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSimona CamoraniNational Academies of Sciences, Engineering, and MedicineBHBilly Samuel HillInstitute of Biostructure and BioimagingRFRaffaela Fontanella

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Camorani et al. (2017) studied this question.

synapsesocial.com/papers/6aabc92bd0633cea78f77f25https://doi.org/10.7150/thno.18974
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization2011 · 240 citations
  2. 2Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers2017 · 93 citations
  3. 3Interaction of MSC with tumor cells2016 · 190 citations
  4. 4Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier2017 · 138 citations
  5. 5Perivascular Human Endometrial Mesenchymal Stem Cells Express Pathways Relevant to Self-Renewal, Lineage Specification, and Functional Phenotype12011 · 219 citations